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Meninges Outside the Meninges: 




Extracranial meningiomas have been reported for decades now and have been 
described in the head and neck; calvarial, nasal cavity, paranasal sinuses, naso-
pharynx, parotid gland and in various remote anatomical locations systemically. 
The presence of microanatomical structures for all intents and purposes resembling 
and having the histopathological characteristics of meninges outside of the central 
nervous system meninges is uncommon but well-documented. Typically, these 
lesions are found in the lung or part of hamartomatous/choristomatous lesions and 
frequently occur in the head and neck anatomical region. The lesion first described 
by Suster and Rosai termed "hamartoma of the scalp with ectopic meningothelial 
elements" is the prototypical example of lesions with meningothelial elements. 
We have described recently a similar hamartomatous lesion with meningothelial 
elements occurring in the tongue. In this chapter, we will review the clinicopatho-
logical features of ectopic meningiomas and lesions that contain meningothelial 
elements and their possible pathogenesis.
Keywords: ectopic, meningioma, meningothelial, hamartoma, choristoma, 
pathology
1. Introduction
This chapter will cover, in brief, clinical and pathological characteristics of what are 
known as primary ectopic meningiomas (PEM) and the presence of tissue histomor-
phologically and immunophenotypically consistent with meningeal tissue (meningo-
thelial) occurring in other organs or as part of teratomas or hamartomas/choristomas. 
PEMs, that is, those that occur outside of the central nervous system (CNS) can occur 
as a result of direct extension of a primary CNS meningioma (through calvarial bone 
into adjacent soft tissue), as a metastatic lesion, or as a primary ectopic meningioma 
[1]. Cutaneous meningiomas or primary cutaneous meningiomas describe a subset of 
PEMs mostly found in the scalp and have a classification system delineated by whether 
lesions are congenital or acquired and whether they have connection to a primary 
intracranial meningioma. Type I are congenital and may present as midline scalp cystic 
lesions (rudimentary meningoceles, acoelic meningeal hamartomas). Rarely sinus 
tracts have been found connecting these to the CNS. Type II are soft tissue meningio-
mas that have predilection for the nose, mouth, eyes, and ears and have no connection 
to an intracranial meningioma. Type III are soft tissue extensions of a primary intra-
cranial meningioma [2]. Meningothelial tissue (not meningioma) can be seen most 
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notably described in the lungs and rarely in hamartomas/choristomas (lesions com-
posed of tissue types arranged haphazardly but indigenous to the location; hamartoma 
or not indigenous to location; choristoma) particularly in the head and neck location. 
PEM have been described in teratomas and meningothelial tissue is not an infrequent 
component of mature neuroglial tissues in teratomas (tumors composed of tissues 
derived from all three primordial germ layers). This review will focus on those some 
aspects of meningiomas that occur outside the CNS; the primary ectopic meningiomas 
and lesions where meningothelial tissue has been found with particular focus on pul-
monary and gonadal (in the context of gonadal mature teratomas) meningiomas and 
meningothelial proliferations and separately hamartomas/choristomas particularly of 
the head and neck. It is these latter lesions that the author has the most familiarity from 
practicing in the discipline of pediatric pathology.
2.  Developmental aspects of meninges pertinent to primary ectopic 
meningiomas and ectopic meningothelial tissue
This will be a brief section and by no means an exhaustive treatment of the 
embryological, morphological and molecular genetics aspects of meninges develop-
ment. For a more thorough review of meninges development, the reader is directed 
to the excellent reviews by Dasgupta and Jeong [3] and Lopes [4]. However, here, 
we will attempt to highlight elements of what is known about the embryological and 
particularly molecular pathways involved in meninges development as it may relate 
to the development of meningiomas and the presence of meningothelial tissues in 
other anatomical locations outside of the central nervous system (CNS) proper.
In contrast to other areas of CNS development, relatively little is known about 
the molecular characteristics of meninges development. In a broad sense, however, 
the meninges increasingly are being shown to be critical to proper calvarial and 
underlying brain development. It is noted that the cranial meninges are derived from 
two cellular pools; the neural crest (ectoderm) and mesoderm. Neural crest derived 
cells can be found in the three layers of meninges covering the forebrain cerebral 
hemispheres but not in the meninges covering midbrain or hindbrain. Calvarial 
development closely parallels meninges development in that the frontal bones are 
primarily neural crest derived while the parietal bones are of mesodermal origin. 
Foxc1 is a key and ubiquitously expressed transcription factor in meninges develop-
ment with noted early upregulation in the primary meninx. Its prominent role is 
demonstrated by lack of apical arachnoid and dura mater formation as well as lack 
of apical calvarial development in Foxc1 mutant mice. Parietal bone development 
appears to depend on the underlying meninges (derived from neural crest) express-
ing transforming growth factor beta 2 receptor (Tgfbr2) as Tgfbr2 mutant mice show 
severe defects in both parietal bone and underlying meninges development. The 
dura or outer dense layer of the meninges becomes closely apposed to the underside 
of the bony calvarium and is the de facto periosteal layer. The mesenchyme around 
the developing brain is divided into layers that include a dermal layer (dermis of 
scalp), skeletogenic layer (skull), and then the meningeal primordium. By extension, 
it can be plausible that ectopic meningiomas can arise (and indeed do) in the bones 
of the calvarium and scalp. It has been proposed that arachnoid cells or precursors 
can migrate with cranial nerves as they exit their foramina during development and 
be the forerunners of primary ectopic meningiomas in anatomic regions such as the 
orbit, ear, and neck [1]. Meninges appear to play crucial roles in brain development 
including providing trophic factors for neuronal survival, migration/positioning of 
neurons, neuronal generation from neuronal progenitors, blood vessel development, 
corpus callosum development, and may provide a niche for neural stem cells [5]. 
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Again, by extension, it is not implausible to think that since much of the structures 
comprising the head and neck are derived from neural crest (and mesenchymal) 
cells, cells with multipotent capabilities, that some of these cells could be dormant 
and later directed down a path of meningeal differentiation in aberrant locations.
3. Primary ectopic (extracranial) meningiomas
To begin this section with an aside, the designation of ectopic meningiomas as 
“primary” necessarily implies that there may be other categories of meningiomas as 
“secondary”, “tertiary” and so on. The terminology “primary ectopic meningioma” 
(PEM for brevity sake) then designates those meningiomas that are outside of the 
CNS that develop presumably from separate meningeal precursor cells; either ectopic 
arachnoid cells or perhaps cells that are multipotent (e.g. neural crest) as we have briefly 
noted. In some sense, this terminology is redundant since if the meningioma (or any 
lesion) is designated as “ectopic” that lesion is not indigenous to its normal anatomic 
location and would therefore be “primary”. So called “secondary extracranial meningio-
mas” are defined as those lesions that are an extension of an intracranial meningioma. 
The author has not seen further designations of meningiomas beyond secondary and it 
is difficult to conjure a scenario where the designation of “tertiary extracranial menin-
gioma” would be applicable. In addition, in perusing this literature, the terminology is 
a bit confusing because different names have been applied descriptively to lesions that 
probably ultimately fall under an umbrella category (see above description of Type I 
cutaneous meningioma). Some have described extracranial meningothelial prolifera-
tions in four categories: 1) extracranial extension of intracranial meningioma, 2) extra-
cranial meningioma, 3) the aforementioned primary cutaneous meningioma, and 4) 
metastatic meningioma [6]. We already see that category 1 is what has been referenced 
as a Type III cutaneous meningioma and 3 presumably encompasses the spectrum of 
cutaneous meningiomas that include Type III. In this author’s simplistic way of thinking 
and since this is a review, primary ectopic meningioma is not an unreasonable designa-
tion because the terms denote a meningioma that is outside the CNS as a “stand alone” 
or primary tumor in that location. If the designation were only “ectopic meningioma” 
then extracranial extensions of intracranial meningiomas could technically be under 
that rubric. Additionally, and similarly, the term “meningothelial” seems to imply tissue 
that is by all standards meningeal but not a tumor (more later). Meningothelial tissue 
or proliferations would seem by definition to be primary and ectopic since intracranial 
meningothelial proliferations are really not a diagnostic category of CNS lesions except 
for the possibility of meningeal tissue as part of another tumor.
That aside, it is interesting when trying to quell cases of PEM from the searchable 
medical literature, the variety of names given to these lesions as hinted at, and the ensu-
ing difficulty that arises in attempting to exactly define the numbers and types of PEM 
reported. As Gibson and Prayson aptly alert the reader in their excellent chapter on 
this subject [7], a variety of designations have been used when reporting these lesions 
including ectopic, extracranial, extraneuraxial, extradural, cutaneous, intraosseous, 
calvarial etc. In addition, case reports may designate one of these categories to describe 
the lesion, but indeed the lesion may actually represent a secondary extracranial menin-
gioma, or the patient may have had a previous remote intracranial meningioma.
Combined with a previous review of 178 reported cases from the English 
language medical literature by Lang et al. [8], Gibson cited an additional 100 cases 
of PEM at the time of publication of their chapter (2009). In this author’s brief 
survey of the entire medical literature not restricted to the English language from 
1/1/2008 to the present, approximately 184 cases of PEM are noted after using 
search terms that Gibson identified as descriptors for PEMs such as “ectopic”, 
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“extracranial”, “extraneuraxial”, “extradural”, “cutaneous”, “calvarial”, “intraosse-
ous” and “meningioma”. By far, the most cases are reported from the head/neck 
anatomic location with intraosseous PEM by far exceeding any other location in the 
head and neck or elsewhere outside of the head and neck (Table 1). The most com-
mon site/location for PEM outside the head and neck was interestingly pulmonary 
followed by spinal/mediastinal/thoracic (Table 2).
It should not be terribly surprising that from a teleological perspective and given 
the developmental biology of meninges that the most commonly cited location of 
PEM is in the head and neck location and more specifically in the calvarial/skull 
bones. The intimate association of mesenchymal and/or neural crest cells in the devel-
opment of the calvarial bones and meninges, particularly the dura which is directly 
apposed to the bone, makes this causative possibility very plausible. Likewise could be 
said for the greater number of cases of PEM found in the spinal/mediastinal/thoracic 
location. In children, certain tumors particularly neuroblastoma and its variants, can 
be found in this paraxial location along the sympathetic chain where neuroblasts are 
migrating during development.
PEM are quite uncommon as might be expected and the multiple reviews all cite 









Soft tissue (thigh) 1
N = 67
Table 2. 















Approximate location and number of primary ectopic meningiomas in the head and neck from 2008 to present.
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excellent reviews have been published identifying the clinical and pathological 
characteristics of PEM in general and in specific locations including intraosseous 
(calvarial) [9], ear and temporal bone [10], sinonasal tract [11], and pulmonary 
[12–15]. In addition, PEMs have been reported in skin, kidney, retroperitoneum, 
mediastinum, extremities, adrenal gland, ovary (mature cystic teratoma) [7], In 
general, for PEM, in contrast to CNS meningiomas, there is only a slight female 
predominance in incidence with the exception of perhaps those presenting in the ear 
and temporal bone where at least in the series by Rushing et al., the M:F ratio (1,2) 
more closely approximated the M:F ratio for CNS meningiomas in adults [16]. PEM 
arising in the ear and temporal bone are particularly troublesome for the pathologist 
as they can have a broad differential diagnosis in a location that is not the genesis of 
a comparatively large number of specimens that might traverse a general patholo-
gist’s microscope. This differential diagnosis includes entities such as paraganglioma, 
schwannoma, melanoma, middle ear adenoma or carcinoid, and carcinoma. The 
middle ear was the most common location for these PEMs with a relatively high 
association with cholesteatoma (9/36 cases). A smattering of histological subtypes 
were identified in these PEM and this is the case for PEM in general. The most com-
mon histological subtype identified by far is meningothelial (range 47% to over 90% 
depending on site) followed at a significant distance by atypical or psammomatous 
[16]. As an aside, in searching our pathology archives for cases of meningioma, we 
found approximately 730 cases of meningioma over 20 years, with less than 5 PEMs 
found that were either intraosseous (calvarial) or middle ear (mastoid) (Figure 1) 
and no cases of  extracranial soft tissue, visceral, or pulmonary PEMs.
Figure 1. 
Meningothelial meningioma of the mastoid presenting with tinnitus in a 46-year-old woman. No connection 
to the CNS was seen by imaging or intraoperatively. A: Low magnification view of meningioma composed of 
spindled and epitheliod cells in a whirling pattern with areas of more concentrated fibrous tissue. Scattered 
psammoma bodies were seen throughout the biopsy pieces (arrow, HE 40X). B: High magnification view of the 
relatively bland appearing nuclei with numerous pseudoinclusions, a hallmark nuclear feature of meningiomas 




A few reviews have been published specifically addressing primary pulmonary 
meningiomas (PPM), that is, meningiomas that occur in the lung parenchyma 
as cited. Three of the four reviews included part of the time span included in the 
review here [12, 14, 15]. Our review provides perhaps more emphasis on the patho-
logical phenotypes and concurrence with other tumors than other reviews.
PPMs are interesting entities for several reasons. One, their pathogenesis might 
not be as teleologically obvious compared to PEMs that occur say in the head and 
neck. Two, pulmonary meningothelial proliferations/nodules are not a terribly 
uncommon finding incidentally in lung resections and will be the subject of the latter 
part of this review as part of the spectrum of extracranial/extraneuraxial lesions of 
meningothelial lineage. Three, there are multiple case reports of concurrent CNS and 
pulmonary meningiomas [17] as well as reports of concurrent PEMs in lung and bone 
[18], metastases from CNS meningiomas to the lung [19] in particular, and metasta-
ses from other tumors into CNS meningiomas [20] and even metastases from PEMs 
to the lung [21]. Four, PPM can be mimickers of a primary lung cancer, now the sec-
ond most common cancer in both men and women in the United States and therefore 
should be considered (albeit somewhat down the differential diagnostic list) by every 
pathologist who looks at lung biopsies and resections [22]. Five, pulmonary menin-
gothelial proliferations, either sporadic or diffuse, may even be more troublesome for 
the pathologist. These interesting categories in the spectrum of meningiomas cannot, 
unfortunately, be further elucidated in this brief review.
Table 3 represents a review of the medical literature (English and non-English) 
searched in PubMed using the search terms “pulmonary” or “lung” and “menin-
gioma” contained in the title/abstract from January 1, 2008 to August 16, 2021 
(roughly corresponding to the last cases of PEM reported by Gibson et al. as noted). 
This search yielded 407 results of which 34 case reports were included reporting 
PPM [12–15, 18, 22–50]. One patient had two case reports approximately 10 years 
apart and one article published in a Spanish journal could not be obtained. The 
clinical characteristics (age, gender, location, size, recurrence rate) are in keeping 
with other reviews of PPM [12–15]. The immunohistochemical profiles were also 
in line with other reviews with most PPMs demonstrating staining with epithelial 
membrane antigen (EMA), progesterone receptor (PR), and vimentin. This review 
demonstrated perhaps higher numbers of both WHO grades II and III tumors (if 
presuming the remainder of the undesignated cases were WHO grade I which is a 
reasonably safe assumption).
An interesting aspect in the review of these cases and not overly emphasized 
in other reviews is the seemingly high number of patients with a history of 
other malignancies; almost one-third of the patients (10/34) with one patient 
having multiple (3) other tumors (osteosarcoma, fibrous dysplasia, and giant 
cell tumor of bone). This patient had a somatic mutation in the giant cell tumor 
of H3.3A and a germline mutation of BRCA2. Of course, one must be careful in 
drawing conclusions from a small dataset and in this case the patients with other 
malignancies were all in the age range where other malignancies are not uncom-
mon (mean age 65 years, range 52–80). The malignancies in this group included 
buccal (1) (presumably squamous cell carcinoma), breast (2), gastric adenocar-
cinoma (1), papillary thyroid carcinoma (1), thymoma (1)/renal cell carcinoma 
(1)(same patient), rectal adenocarcinoma (1), concurrent lung adenocarcinoma 
(1) and teratoma (1) (immature and mature teratoma of the ovary and retroperi-
toneum, respectively). With the exception of the teratomas and thymoma, the 
other tumors are not uncommonly seen in this age group. As an aside, the PPM in 
the patient with teratomas does raise the remote possibility of a meningothelial/
meningioma metastases from one of the teratomas particularly since one tera-
toma was designated as immature.
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Characteristic N = 34 cases
Age at presentation (years) (n = 34)
Mean (SD) 57.1 (17.8)
Range 18–108
Median 60
Gender (M:F) 9:25 (1:2.8)
Symptoms at presentation 11 (23- no designation)
Follow-up (n = 17)
Disease free/no recurrence 17
Mean (years) (SD) 3.2 (4.5)
Range 0.17–20


















WHO grade (I, II, III) 28/3/4*
Psammoma bodies 11/15
No designation 20
Epithelial membrane antigen/EMA + 30/30 (5-no designation)
Progesterone receptor (PR) + 17/18 (17-no designation)
Vimentin + 20/20 (15-no designation)
S100 + 6/14 (21-no designation)
Cytokeratins + 0/16 (19-no designation)




*- One patient had two asynchronous tumors.
Table 3. 
Review of clinical and pathological characteristics of primary pulmonary meningioma 2008–2021.
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A 21-year-old female with Diamond-Blackfan anemia was included in this 
cohort who presented with a chordoid histology PPM [39] . Diamond-Blackfan 
anemia (DBA) is an inherited bone marrow failure syndrome that has approxi-
mately 20 known genetic aberrations in genes encoding small/large subunit 
associated ribosomal proteins (RPS and RPL genes) [51]. A cursory review shows 
no definitive RPS or RPL genes to be associated with any of the non-neurofibroma-
tosis, type 2 (NF2) associated genes known to be mutated in meningiomas [52–54]. 
While DBA is associated with higher rates of other cancers including osteosarcoma, 
vaginal squamous cell carcinomas, esophageal cancer, colon adenocarcinoma, and 
myeloid leukemias, increased risk for meningiomas have not been seen in patients 
with DBA to date [51]. However, subsequent to the publication of this young 
patient with DBA and chordoid meningioma, she was found to have a mutation of 
the RSP19 gene [51].
As noted, one patient in this cohort had papillary thyroid carcinoma (PTC). An 
interesting epidemiological study by Sughrue et al. [55] showed that compared to 
the expected prevalence for a similar population, patients with meningioma had a 
statistically higher incidence of papillary thyroid cancer and acute leukemia. From 
a pathology perspective, it is also interesting that both tumors share at least one 
characteristic histopathological feature; psammoma bodies. Psammoma bodies can 
be seen characteristically in several tumors including PTC, meningiomas, serous 
cystadenocarcinoma of the ovary, and melanotic schwannoma (one of the tumors 
with high prevalence in Carney syndrome). The pathogenesis of psammoma 
bodies is still controversial with theories involving vascular thrombosis of papil-
lae, followed by calcification and endothelial necrosis. More recently, osteopontin 
(OPN), a calcium-binding glycophosphotein has been implicated in the formation 
of psammoma bodies being expressed in CD68 positive macrophages along with 
other factors that include alkaline phosphatase, osteocalcin, metalloproteinases, 
bone sialoprotein, and others [56]. OPN expression has been shown to be increased 
in meningiomas compared to normal meninges, correlates with histological grade, 
and is a predictor of recurrence in WHO grade I tumors [57, 58].
The pathogenesis of PPM and PEM particularly those outside of the head 
and neck, of course, remains speculative as do many aspects of normal meninges 
development as noted earlier. Hypotheses regarding the origin of PEMs have 
included ectopic arachnoid cells that are present in cranial and peripheral nerve 
sheaths and in cranial sutures, misplacement of arachnoid cells during develop-
ment, pluripotent mesenchymal cells, perineurial cells of peripheral nerves, and 
entrapped meninges at sites of trauma [7, 16]. Meningiomas, arachnoid cap cells 
(cells making up the outer layer of the arachnoid mater and villi), and spindle cells 
within perineurium express EMA that is detected immunohistochemically. While 
nearly all meningiomas and perineuriomas express EMA, only about one-third of 
meningiomas express glucose transporter-1 (GLUT-1) while most perineuriomas 
express GLUT-1. Similarly, SSTR2 and PR are expressed in a high percentage of 
meningiomas compared to perineuriomas while the reverse is true for claudin-1 
[59]. Indirect support for pluripotent mesenchymal cells as the cell of origin for 
PEMs derives from the fact that meningiomas can exhibit histologically other tissue 
types including bone, cartilage, muscle, vascular, and other tissues. With regards to 
PPM specifically, two theories have arisen regarding their pathogenesis. The first is 
similar to what has been proposed for PEMs elsewhere; pluripotent mesenchymal 
cells that reside in the subpleural region or from “precursor” lesions known as 
minute pulmonary meningothelial nodules (MPMN, more on these later) [12]. 
Both PPM and MPMN share some similar phenotypes particularly the expression 
of similar immunohistochemical markers (EMA, PR, vimentin) but it is certainly 
unclear if MPMNs are truly precursors of PPM. Indeed, there seems to be some 
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discrepancy in incidence of MPMN and meningiomas in autopsy series leading 
some to conclude that MPMN cannot be a precursor lesion [12]. Some have argued 
that MPMN are not precursor lesions based on genotyping studies demonstrating 
higher frequencies of loss of heterozygosity (LOH) and LOH affecting different 
loci in meningiomas compared to MPMN [60]. It is interesting that a progression 
of increasing frequency of LOH was noted from solitary MPMN to meningothelio-
matosis to meningioma. Weissferdt et al. demonstrated that MPMN do share some 
genotypic alterations with PPM and CNS meningioma particularly deletion of the 
NF2 gene and gains of chromosome 22q [61]. The distinction between the two has 
mostly been by somewhat arbitrary size criteria (≤ 3 mm for MPMN). PPMs also 
tend to form a “mass” displacing lung.
From the pathology perspective, PEMs present specific and diverse diagnostic 
challenges. This is largely due to the variable histomorphologies that have been 
described not only in CNS meningiomas but also in PEMs and the various locations 
that PEMs can occur which raise different differential diagnoses. The differential 
diagnoses for PEM in the middle ear and temporal bone has already been discussed. 
For all PEMs in the head and neck location, Rushing et al. found paraganglioma, 
schwannoma, and metastatic carcinomas to be the most frequent misdiagnoses for 
ear and temporal bone PEM; Carcinoma, melanoma, olfactory neuroblastoma, and 
aggressive psammomatoid ossifying fibroma for sinonasal tract PEM, and derma-
tofibroma, melanoma, fibrosarcoma, leimyosarcoma, and synovial sarcoma for 
soft tissue and skin PEM [16]. The differential diagnosis for PPMs brings a variety 
of entities that can occur in the lung and mediastinum. These include sarcoma-
toid mesothelioma, solitary fibrous tumor, spindle cell thymoma, spindle cell 
carcinomas, inflammatory myofibroblastic tumor, synovial sarcoma, epithelioid 
hemangioendothelioma, and of course metastases [12]. As noted, meningiomas can 
present with a wide range of histological features including meningothelial, fibrous, 
microcystic, transitional (spindle cell component) psammomatous, angiomatous, 
secretory, metaplastic (lipidized cells), lymphoplasmacytic rich (all WHO grade 
I), clear cell (mimicking clear cell renal cell carcinoma), chordoid, atypical (WHO 
grade II), and rhabdoid (cells with eccentric nuclei and abundant eosinophilic 
cytoplasm), papillary, and anaplastic (WHO grade III). There are several excellent 
reviews of the histopathology of meningiomas along with the criteria for atypical 
and anaplastic variants [52, 54, 62]. And as mentioned before, other tissue types can 
be seen occasionally within meningiomas (i.e. bone, cartilage/chondroid, muscle). 
The variety of tissue types and potential to produce other tissues speaks highly for a 
pluripotent cell of origin (neural crest, mesenchymal) and are reminiscent of some 
other tumors that have such potentially variable histological appearances (e.g. yolk 
sac/endodermal sinus tumor which is derived from a pluripotent cell). Suffice it to 
say that given these variations, the differential diagnoses become expanded and 
criteria for narrowing the diagnoses are critical. Most of the identified histological 
subtypes have been identified in PEMs. In the review by Rushing et al. of extracra-
nial head and neck PEMs, meningothelial, psammomatous, clear cell, atypical, and 
anaplastic were noted [16]. In sinonasal tract meningiomas, meningothelial is the 
most common subtype and transitional, metaplastic, and psammomatous types 
have been identified [11]. In PPMs, as noted in this review and others, meningothe-
lial, transitional, fibrous, chordoid, rhabdoid, psammomatous, atypical, and ana-
plastic have been reported. Transitional histology is reported as the most common 
histological subtype in PPMs [12]. As seen in our review and noted in many publica-
tions, the immunohistochemical trio of EMA, vimentin, and progesterone receptor 
is present in the majority of cases of meningioma including PPMs. A smattering of 
cases will show staining with CD34, S100, and CD68 but are almost always nega-
tive for cytokeratins. In cases where these stains and morphology still leave doubt, 
Brain Tumors
10
other markers should be included in the work-up panel. A cytokeratin stain (both 
high and low molecular weight or pankeratin) is very important in the exclusion of 
entities such as metastases from carcinoma, mesothelioma, and thymoma. Neural 
markers (chromogranin, synaptophysin) are usually negative in meningiomas 
and positive in paragangliomas for instance. CD56 has been shown to mark some 
meningiomas (4 positive cases in our series although most cases in the series did not 
perform or report this marker) but is also strongly positive in most paragangliomas. 
Since melanoma can be a great mimicker of many tumors, markers such as HMB-45, 
melan-A, MART1, and MITF are helpful in this distinction since these are almost 
always negative in meningiomas. S100 may be useful also in the distinction of 
melanocytic tumors and peripheral nerve sheath tumors (schwannoma) with usual 
strong diffuse staining of these entities. However, as seen, 6/14 cases that reported 
results of S100 staining in PPMs were positive in our series. While most did not 
report the extent or intensity of staining for S100, in general, it is probably not to 
the degree seen in melanocytic or peripheral nerve sheath tumors. Vascular mark-
ers, CD31 and CD34, can be helpful since most meningiomas are negative for these 
markers. These vascular markers should be positive in hemangioendothelioma. 
CD34 is usually positive in solitary fibrous tumor along with bcl-2 and is almost 
always negative for EMA. Bcl-2 is also useful for distinguishing synovial sarcoma. 
Muscle markers (smooth muscle actin, muscle specific actin, calponin and oth-
ers) can helpful in the distinction of smooth muscle neoplasms and inflammatory 
myofibroblastic tumors along with ALK-1.
Another marker that demonstrates very high positive and negative predictive 
values for meningiomas is the monoclonal antibody to SSTR2a (somatostatin recep-
tor 2a) [63]. This receptor is highly expressed in meningiomas as are other soma-
tostatin receptors. Somatostatin ligand analogs such as DOTATOC and DOTATATE 
have been linked to 68Ga and used in PET imaging of meningiomas with great 
success. 68Ga-DOTATATE uptake correlates with SSTR2 expression and has high 
sensitivity for detecting active tumor in untreated and recurrent meningiomas [64]. 
In tissue specimens, the monoclonal antibody to SSTR2a has higher sensitivity than 
EMA or PR and did not stain with high intensity other lesions in the differential 
diagnoses including peripheral nerve sheath tumors (malignant and benign) and 
other carcinomas, mesenchymal tumors, or melanomas [63]. A high percentage of 
meningiomas also express p40 which is one isoform of p63 (p53 homolog gene) and 
the intensity of expression correlates with histological grade and recurrence [65].
All meningiomas are not sporadic. Multiple familial syndromes associated with 
specific genetic aberrations have increased risk for development of meningiomas. 
Neurofibromatosis 2 (NF2 gene, chromosome 22q12) has the highest lifetime risk 
for development of meningioma at 50%. Approximately 40% of sporadic meningi-
omas are driven by other genetic mutations other than NF2 [54]. Table 4 highlights 
the known familial syndromes associated with varying degrees of increased risk of 
meningioma. As somewhat of an aside, patients with Werner syndrome (Progeria, 
premature aging syndrome) as noted have an increased risk of meningioma. In the 
excellent review by Lauper et al. [66], they noted 27 meningiomas in their cohort 
of 189 confirmed Werner syndrome patients. Eight of these tumors occurred in 
patients with multiple tumors and 5/9 patients with meningiomas also had thyroid 
neoplasia (1 PTC, 1 thyroid carcinoma NOS, 3 adenomas). Four of 5 patients had 
only meningioma and thyroid neoplasia as manifestation of their multiple tumors. 
Gardner/Turcot syndrome (APC-associated polyposis), PTEN hamartoma syn-
drome (Cowden, Bannayan-Riley-Ruvalcaba, Lhermitte-Duclos syndromes), MEN1 
(Wermer syndrome), and Werner syndrome are familial inherited syndromes 
also highly associated with thyroid neoplasia [67]. Carney complex also has a high 
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association of thyroid neoplasia and has as a pathognomonic lesion the melanotic 
schwannoma, a tumor characterized by schwannian differentiation with the 
feature of psammoma bodies. Carney complex is known to result from mutations in 
PRKAR1A (chromosome 17q22–24) and CNC2 (2p16) while WHO grades II and III 
meningiomas have been shown to be associated with gains and amplification of 17q 
[53, 54, 67]. In addition, interestingly, Gardner/Turcot syndrome, Carney complex, 
and Werner syndrome all have various bone tumors as part of the manifestation/
diagnostic criteria for their respective syndromes. In the review by Lauper et al. 
[66], 17/189 Werner syndrome patients had osteosarcoma with 7/19 osteosarcomas 
occurring in patients with multiple tumors and one of these patients had menin-
gioma/thyroid adenoma/osteosarcoma as the manifestation of multiple neoplasia. 
Another association is the presence of neoplasia associated with derivatives of 
the neural crest (retinal epithelial hypertrophy, benign and malignant peripheral 
nerve sheath tumors, benign and malignant melanocytic lesions). Gardner/Turcot, 
Carney complex, PTEN hamartoma, Werner syndromes all have melanocytic 
lesions as part of their neoplasia spectrum.
These are very interesting associations and can and will lead us to further 
elucidation of unifying mechanisms of molecular and cellular origins of tumors 
and in this case meningiomas. It is worth noting here that there are very few reports 
of PEMs associated with a familial inherited syndrome. What was presented above 
was data for associations with primary CNS meningiomas. Very few reports of 
PEMs in patients with a familial syndrome can be found. One case report describes 
an ectopic meningioma of the right parapharyngeal space in a 14-year-old girl with 
NF2 [68]. A second report describes an intranodal meningothelial proliferation in 
a 55-year-old woman with confirmed Cowden syndrome [69]. There seems likely 
a true difference in familial genetic syndromes and association with PEMs since 
one would think that specific case reports would address this as part of the unique 
spectrum of individual presentations of PEM.
Familial syndrome Gene Chromosome location Risk %
Neurofibromatosis 2 NF2 22q12 >50
Multiple spinal meningiomas SMARCE1 17q21.2
BAP1 tumor predisposition BAP1 3p21.1 2
Familial schwannomatosis SMARCB1 22q11.23
Gorlin syndrome PTCH1 9q22.3 5
Cowden disease PTEN 10q23.31 8
Familial multiple meningiomas SUFU 10q24.32
Li-Fraumeni TP53/CHEK2 17p13.1/22q12.1
Rubinstein-Taybi CREBBP 16p13.3
Gardner syndrome/Turcot syndrome APC 5q21–22
Multiple endocrine neoplasia I MEN 11q13
Werner syndrome WRN (RECQL) 8p11.1–21.2 14
Von Hippel–Lindau VHL 3p25.3
Ataxia telangiectasia ATM 11q22
Table 4. 




I suppose a general definition of “meningothelial proliferation” would likely 
be in order. It was alluded to earlier in this review. I say “general” because as 
noted in the case of PPMs the distinction between what is a meningothelial 
nodule/proliferation and what is termed a meningioma may be a bit arbitrary and 
certainly subjective. In this review of PPM, for instance, 6/31 “meningiomas” 
were less than 1 cm in greatest dimension. In pathology, the distinction between 
what determines a proliferation and what determines a “tumor” is sometimes 
based on size with 1 cm being a threshold size for specific tumor designations. 
For instance, the distinction of papillary thyroid microcarcinoma and papillary 
thyroid carcinoma is based on the former being less than 1 cm in greatest dimen-
sion. In radiology, the standard threshold for detecting tumors has traditionally 
(although not as much now with improvements in imaging modalities) been less 
than or greater than 1 cm. In the practice of pathology, these distinctions are not 
always clear and other features in addition to size are considered in the diagnostic 
algorithm. An important feature is what the tumor is doing to the surrounding 
tissue. Is it “blending” in as in the cases, for example, of dominant hyperplastic 
nodules in the thyroid or nephroblastomatosis in the spectrum of Wilms tumor or 
it is replacing/pushing normal tissue.
With regards to meningothelial proliferations that occur outside the CNS, that is 
the presence of meningothelial or meningeal tissue that is not a tumor of meninges, 
these have been described in a few general settings (although not an exhaustive list) 
including heterotopic neuroglial proliferations, pulmonary meningothelial nodules 
(to include diffuse pulmonary meningotheliomatosis), teratomas, and rarely in 
choristomatous lesions particularly in the head and neck.
One of the reasons to include a review of PPM as cited above was that menin-
gothelial proliferations are well-described in the lungs. In the older pathological 
literature, MPMNs were originally termed “minute pulmonary paragangliomas” or 
“chemodectomas” since their ontogeny was thought to be distal airway chemorecep-
tors [70]. However, subsequently, these have been shown not only morphologically 
but immunohistochemically and ultrastructurally to be meningothelial in origin. 
They present as a nested proliferation of spindled and epithelioid cells with bland 
nuclei around small veins in the lung and exhibit the characteristic EMA+, vimen-
tin+, and PR+ immunophenotype. The incidence of MPMN is reported up to 5% 
in autopsy studies and in up to approximately 14% of surgical biopsy specimens 
and in nearly half of lobectomy specimens [70]. Interestingly, in the large series by 
Mukhopadhyay that included resections from patients in the pediatric age range and 
over 90 pediatric autopsies, no MPMN were seen in the pediatric population [71]. 
Radiographically, by CT, MPMN are round solid or partially solid nodules and can 
be multiple and have a “ground glass” appearance. They typically show low SUV 
(benign) values for FDG-avidity on 18F-FDG PET-CT imaging [13]. Depending on 
the clinical scenarios (concurrent other lung lesions, history or concurrence of other 
tumors), metastases or synchronous tumors cannot be entirely excluded thus necessi-
tating removal and pathological examination. Rarely, MPMN can occur in the setting 
of PPM; some of these cases being diagnosed as intrapulmonary metastases [14, 25].
Diffuse pulmonary meningotheliomatosis (DPM) is an interesting if not quite 
rare entity. These patients can present with symptoms of restrictive pulmonary 
disease with diffuse bilateral reticulonodular infiltrates that have the differential 
diagnoses including a variety of interstitial lung diseases, carcinomatosis, neuro-
endocrine tumorlets, metastatic meningioma, and pulmonary lymphangioleio-
myomatosis (PLAM). The separation of these entities is relatively straightforward 
based on morphology and immunophenotyping. Metastatic meningiomas should 
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be distinguished by clinical grounds (presence of a CNS tumor), involvement of the 
bronchovascular tree as opposed to DPM which is usually found centered around 
small veins, and more atypical appearance. Carcinomatosis, neuroendocrine 
tumorlets, and PLAM are distinguished by positivity for keratins, neuroendocrine 
markers (typically synaptophysin and chromogranin), and actins while similarly 
to MPMN and PPM, DPM lesions are EMA, vimentin, and PR positive [61, 71–73]. 
Primary pulmonary meningothelial lesions (MPMN, DPM, and PPM) are very 
interesting from developmental and genetic perspectives as lung meningothelial 
lesions seem to predominate the epidemiological landscape of meningothelial 
lesions outside of the CNS and head/neck and seem to have an extremely low 
prevalence in the pediatric population leading some to speculate that their origins 
may not be pluripotent mesenchymal cells but more related to environmental and 
age-related factors. Although, just because they are not found in the pediatric age 
group, should not totally discount that they arise from resting pluripotent stem cells 
or other dormant embryological remnants and their recrudescence as meningo-
thelial lesions is stimulated by other factors. The lungs like other organs also have a 
“stem cell niche” that is triggered when there is bronchial epithelial injury for the 
purposes of regeneration/repair [74]. As we have also discussed there seems to be a 
spectrum of increasing mutations in MPMN and DPM raising the possibilities for a 
mutational spectrum or “hit” hypotheses in their pathogenesis.
Meningothelial tissue can occur as part of other pathological lesions. In this final 
section we will briefly touch on the presence of meningiomas and meningothelial 
tissue in teratomas and meningothelial elements as part of heterotopic/choristo-
matous/hamartomatous lesions. Somewhat surprisingly, very few cases of menin-
gioma or meningothelial tissue in teratomas are described. A search of PubMed for 
“meningiomas” and “teratomas” yielded 8 results. One case was a posterior fossa 
tumor mimicking a meningioma and another case was teratoma and meningioma in 
the temporoparietal region. The remaining 6 cases were all gonadal teratomas with 
meningioma [75–82]. The clinical and pathological characteristics of these meningi-
omas is presented in Table 5. Two cases were in the pediatric age range (5-year-old 
male and 15-year-old female and all meningiomas were seen on gross examination 
to be whitish or brown firm nodular areas within the broader context of the mature 





Age (years) (SD) 33.8 (20.7)
Range 5–60
Size (cm) (SD) 2.7 (1.2)
Psammoma bodies 5/6
Epithelial membrane antigen/EMA + 5 (1 with no designation)
Vimentin + 2 (4 with no designation)








Meningeal/meningothelial tissue within a mature cystic teratoma of the ovary in a 13-year-old girl.  
A: Low magnification view showing mature neuroglial tissue (upper left corner) adjacent to a proliferation 
of rarified, wispy anastomosing cords of fibrous tissue lined by bland small indistinct nuclei. In other areas 
of the teratoma, this pattern was also seen adjacent to skin and adnexal structures. This segregation of the 
meningothelial elements near skin and mature neuroglial is common. (HE, 40X). B: Weak by definite staining 
of the meningeal tissue with epithelial membrane antigen (EMA, 200X). C: Variably intense staining with 
progesterone receptor (PR, 400X). D: Diffuse strong intensity staining with vimentin (vimentin, 200X).
cystic teratoma (MCT). Chen et al. searched for and characterized meningothelial 
proliferations in 25 consecutive ovarian MCT [83]. They found that 40% of their 
tumor had meningothelial proliferations that resembled what has been described in 
hamartoma of the scalp with ectopic meningothelial elements (more on this later). 
The meningeal nature of the tissue was confirmed morphologically and by EMA 
positivity. In all cases the meningothelial tissue was in close association with skin 
and mature glial tissue (ectodermally derived). Eight of 10 cases had pigmented 
cells and 3 had psammomatous calcifications. In the author’s anecdotal experi-
ence, having microscopically examined numerous teratomas from children and 
adults and teratomas derived from the harvested embryonic stem cells from several 
species, the finding of meningeal tissue seems not that uncommon, although I have 
not encountered a meningioma tumor. A recent case of mine illustrates this from 
a 13-year-old girl with MCT. The meningeal tissue is intimately associated with 
mature neuroglial tissue and resembles arachnoid of the meninges (Figure 2).
Meningothelial tissue can be part of lesions described as heterotopias, particu-
larly of the neuroglial flavor, hamartomas, and choristomas (tissues not indigenous 
to the anatomic location). In 2005, we reported a temporal glioneuronal heterotopia 
in a 19-month-old child without underlying connection to the CNS or calvarial 
defect. In our review of similar cases from the medical literature to that time, 11 
infants were identified ranging in age from birth to 15-months. Six of 11 cases had 
no connection to the CNS (true heterotopias) and 2/6 had meningothelial elements 
as a component histologically [84]. In another review published at approximately 
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the same time by Rogers et al. from Boston Children’s Hospital, they reported 11 
patients with 12 tumors of the scalp ranging in age from 1-month to 20-months. 
Seven of the 12 tumors had no connection to the CNS and 5 of those 7 tumors had 
meningothelial tissue as a prominent component histologically [85].
Ectopic meningothelial tissues have been described that appear to arise entirely 
within the skin and often present in the neonate or infant (so called Type I cutaneous 
meningioma; defined in the beginning of this chapter). These have been previ-
ously termed “acoelic meningeal hamartoma” “cutaneous heterotopic meningeal 
nodules” and “rudimentary meningocele”. In the series published in 1989 by Sibley 
and Cooper referenced earlier, they described 5 cases of what they termed “primary 
cutaneous meningioma”. What they describe histologically is what is expected in 
meninges both morphologically and immunophenotypically including collagenous 
bodies and psammomatous calcifications. Some areas in the superficial dermis had a 
more rarified and lacy appearance with meningocytes wrapping around vessels and 
adnexa in intimate association similar to that described shortly thereafter by Suster 
and Rosai [86]. Their series described 5 patients who had pseudoinfiltrative lesions 
of the skin and subcutis by meningothelial elements that were in intimate associa-
tion with the surrounding tissue elements (vessels, fat, connective tissue). In fact, 
they designated that the meningothelial elements were an interspersed component 
between a proliferation of connective tissue elements. Their designation for these 
lesions was “hamartoma of the scalp with ectopic meningothelial elements” and 
this has become the diagnostic term for such lesions. More recent reports in some 
cases have shortened the nomenclature to “meningothelial hamartoma”. Suster and 
Rosai give the poignant perspective that the designation of these hamartomatous 
lesions with meningothelial elements are distinguished from primary cutaneous 
meningiomas by the association with other poorly arranged elements constituting 
a hamartoma. We have encountered similar tumors in the scalp (Figure 3A and B) 
and have published two cases in young children of tongue lesions with meningo-
thelial elements (Figure 3C and D). Both tongue lesions were entirely composed 
of the typical anastomosing slit-like channels lined by bland flat-to-cuboidal cells 
expressing progesterone receptor and epithelial membrane antigen. Interestingly, 
but not surprisingly, meningothelial elements have been described occurring in the 
rare “teratoid” lesion of the palate known as hairy polyp [6]. These are pedunculated 
growths that can be composed of a variety of tissues derived predominantly from 
ectodermal and mesodermal (mesenchymal) germ layers. In the reported case, the 
presence of meningothelial tissue was confirmed by immunohistochemistry and 
ultrastructural examination demonstrating the characteristic interdigitating cyto-
plasmic processes connected by cell junctions, desmosomes, intermediate filaments 
(hence positive expression of vimentin).
In summary, CNS meningiomas are the most common primary CNS tumor and 
meningiomas and meningothelial tissue/proliferation occur in a multitude of extra-
CNS sites and present in a diverse manner from isolated non-tumor proliferations 
to part of hamartomatous lesions to diffuse meningotheliomatosis to meningiomas 
tumors arising in multiple anatomic locations. Morphologically, immunopheno-
typically, ultrastructurally, and perhaps genetically, the meningeal tumors and 
proliferations outside the CNS are very similar to their CNS counterparts suggesting 
a common cellular origin. Because of the possibility of arising in diverse anatomic 
locations, they join a long list of differential diagnostic considerations for the 
practicing pathologist and should be entertained as possibilities particularly when 
the morphology could significantly overlap other tumors. In most cases, the immu-
nohistochemical profile of EMA, vimentin, progesterone receptor, and SSTR2a (if 
available) is diagnostic in the proper morphological context. This panel should be 
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Figure 3. 
Examples of ectopic meningothelial proliferations in the head and neck. A and B represent “hamartoma 
of the scalp with ectopic meningothelial elements” in a young child. 3A: Low magnification view of loose 
proliferation of anastomosing wispy fibrous cords lined by bland nuclei interdigitating around adnexal 
structures (HE, 40X). 3B: High magnification view of the microarchitecture of meningothelial proliferations. 
This pattern closely resembles vascular proliferations, particularly lymphatic malformations in children 
and must be excluded in the differential diagnosis (HE, 400X). C and D are from a nearly 2-year-old boy 
with a tongue mass. 3C: Less obvious than the previous case shown here yet the same microarchitectural 
pattern is appreciated below the surface epithelium of the tongue. This rarified pattern might be considered a 
“hemangiopericytomatous” pattern but in any case, is abnormal for the submucosa of the tongue (HE, 40X). 
3D: This meningothelial proliferation show strong nuclear staining for progesterone receptor (PR, 400X).
© 2021 The Author(s). Licensee IntechOpen. This chapter is distributed under the terms 
of the Creative Commons Attribution License (http://creativecommons.org/licenses/
by/3.0), which permits unrestricted use, distribution, and reproduction in any medium, 
provided the original work is properly cited. 
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